Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Open Access
- 19 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 14 (3), 276-286
- https://doi.org/10.1038/ncb2432
Abstract
Tissue stromal cells interact with leukaemia cells and profoundly affect their viability and drug sensitivity. Here we show a biochemical mechanism by which bone marrow stromal cells modulate the redox status of chronic lymphocytic leukaemia (CLL) cells and promote cellular survival and drug resistance. Primary CLL cells from patients exhibit a limited ability to transport cystine for glutathione (GSH) synthesis owing to a low expression level of Xc-transporter. In contrast, bone marrow stromal cells effectively import cystine and convert it to cysteine, which is then released into the microenvironment for uptake by CLL cells to promote GSH synthesis. The elevated level of GSH enhances leukaemia cell survival and protects them from drug-induced cytotoxicity. Furthermore, disabling this protective mechanism significantly sensitizes CLL cells to drug treatment in the stromal environment. This stromal–leukaemia interaction is critical for CLL cell survival and represents a key biochemical pathway for effectively targeting leukaemia cells to overcome drug resistance in vivo.Keywords
This publication has 69 references indexed in Scilit:
- Measuring the poise of thiol/disulfide couples in vivoFree Radical Biology & Medicine, 2009
- Regulation of glutathione synthesisMolecular Aspects of Medicine, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- Glutathione Depletion and Disruption of Intracellular Ionic Homeostasis Regulate Lymphoid Cell ApoptosisPublished by Elsevier BV ,2008
- Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanismBlood, 2008
- Glutathione Depletion Is Necessary for Apoptosis in Lymphoid Cells Independent of Reactive Oxygen Species FormationPublished by Elsevier BV ,2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removalBlood, 2006
- BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathwayBlood, 2006
- Basic fibroblast growth factor (bFGF) upregulates the expression of bcl-2 in B cell chronic lymphocytic leukemia cell lines resulting in delaying apoptosisLeukemia, 1997